[Research advances in the role of interleukin-21 in chronic hepatitis B virus infection]
- PMID: 27465956
- DOI: 10.3760/cma.j.issn.1007-3418.2016.06.017
[Research advances in the role of interleukin-21 in chronic hepatitis B virus infection]
Abstract
Interleukin-21 (IL-21) is a cytokine mainly secreted by activated CD4+ T cells and natural killer T cells and has multiple effects. It is involved in innate and adaptive immune responses. Recent studies have shown that IL-21 can promote functional activation of various immune cells in the process of hepatitis B virus (HBV) infection, and the gene polymorphisms of IL-21 is associated with the susceptibility to HBV. In addition, the expression of IL-21 is closely associated with HV genotype, HBV clearance, HBeAg seroconversion, HBV-related liver cirrhosis, liver failure, liver cancer, and autoimmune disease. This article reviews the research advances in clinical trials with reference to the aspects above.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials